Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Shital Patel

HIV/AIDS Medicine · BCM

View

Dr. Monica Gandhi

HIV/AIDS Medicine · UCSF

View

Dr. Ashwin Balagopal

HIV/AIDS Medicine · Johns Hopkins

View

Dr. Ofole Mgbako

HIV/AIDS Medicine · NYU Langone

View

Dr. Joshua Barocas

HIV/AIDS Medicine · CU Anschutz Medical Campus

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Keith Kaye

General ID · RU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    KGDr. Kelly Gebo

    Dr. Kelly Gebo

    Infectious Disease · HIV & AIDS Medicine
    George Washington University
    kellyg

    Research

    COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval

    2026

    Via Expert Review of Anti-Infective Therapy

    Research

    Patient-Directed Discharge Among Hospitalized Persons With Opioid Use Disorder in the Fentanyl Era: A Scoping Review

    2026

    Via American Journal of Medicine Open

    Research

    Targeted cuts to Ryan White programs could raise HIV incidence by 8-17% in 30 US states and the District of Columbia

    2026

    Via AIDS

    Research

    New to Cohort, Not New to Care: Leveraging Historical Data in HIV Clinical Cohorts in the United States

    2026

    Via American Journal of Epidemiology

    Apr 30, 2026Journal Article

    The Potential Effect of Ending Centers for Disease Control and Prevention Funding for HIV Tests: A Modeling Study in 18 States.

    ​

    Written by 1 Roon author & 10 others

    Via Clinical Infectious Diseases

    Research

    Projected Increase in HIV Incidence in 11 States if Ryan White Ends: A Simulation Study

    2026

    Via American Journal of Public Health

    Research

    Impact of SARS-CoV-2 Breakthrough Infection on Short-Term CD4 Count Among Adults With HIV in the United States From 2020 to 2022

    2026

    Via Open Forum Infectious Diseases

    May 14, 2026Original Article

    Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts

    ​

    Written by 1 Roon author & 15 others

    Via The New England Journal of Medicine

    Research

    Effects of HIV status and vaccination on long COVID conditions within an integrated health care system

    2026

    Via Communications Medicine

    Dec 24, 2025Journal Article

    Incidence of AIDS-Defining Conditions Among Adults With Perinatally Acquired HIV After Transition to Adult HIV Care in the United States and Canada, 2000-2022.

    ​

    Written by 1 Roon author & 11 others

    Via Clinical Infectious Diseases

    Research

    The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2

    2025

    Via Microbiology Spectrum

    Research

    Patient-Reported Outcomes of Nirmatrelvir Treatment for High-Risk, Nonhospitalized Adults With Symptomatic COVID-19

    2025

    Via Open Forum Infectious Diseases

    Research

    T cell immunity to seasonal Influenza A and H5N1 viruses in laboratory workers receiving annual seasonal Influenza vaccines

    2025

    Via Frontiers in Immunology

    Research

    Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process

    2025

    Via The Lancet HIV

    Research

    When public health emergencies hit the front line: a qualitative study of the patient experience in the emergency department and outpatient infectious disease clinic during the 2022 Mpox clade IIb outbreak

    2025

    Via BMC Infectious Diseases